Commercializing on your Own: A Panel Discussion with Insights from Emerging Biopharma Executives

Oct 03, 2018
By IQVIA

Register Free: http://www.pharmexec.com/pe_w/biopharma

For any life sciences company bringing its first product to market, the “commercialization to-do list” is long and punctuated by one critical strategic decision after another. What are the variables driving your launch strategy? What tools should you have in place to support marketing and sales? How can you ensure compliant transparency reporting and mitigate risk? Often in as little as 18 months, you’ll need to pull together – or access – an entire commercial organization and infrastructure. So where do you start?

Hear from a panel of emerging biopharma executives who have faced these challenges, and more, as they built their commercial operations function from the ground up. They will share best practices and lessons learned based on their experiences launching in the US and in Europe.

3 Key take-aways

  • Understand how to identify and plan for the investment you’ll need to bring the product to market (and gain stakeholder support)
  • Determine how and when to ramp up the building blocks of your commercial infrastructure with a ‘just-in-time’ execution
  • Discover ways to develop an efficient and effective commercial operation that can scale appropriately with the trajectory of your launch

 

Speakers:

Timothy Kneen, Executive Vice President, Global Commercial Operations, Theramex

David Richards, Sr. Director, Brand Commercial Operations, Lupin Pharmaceuticals

 

Date and Time:

Live: Wednesday, October 3, 2018 at 11 am EDT

After the final airing of the webcast on October 3, 2018 it will be available on demand until October 3, 2019. 

Sponsor: IQVIA

Register Free: http://www.pharmexec.com/pe_w/biopharma

native1_300x100
lorem ipsum